258 related articles for article (PubMed ID: 7202134)
21. Very long-chain fatty acids in erythrocyte membrane phospholipids in adrenoleukodystrophy.
Tanaka K; Shimada M; Naruto T; Yamamoto H; Nishizawa K; Saeki Y
Acta Paediatr Jpn; 1989 Apr; 31(2):136-43. PubMed ID: 2516693
[TBL] [Abstract][Full Text] [Related]
22. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
[TBL] [Abstract][Full Text] [Related]
23. Adrenoleukodystrophy. Validity of CT in the diagnosis.
Pavone L; Pero G; Fiumara A; La Rosa M; Scialfa G
Ital J Neurol Sci; 1982 Mar; 3(1):71-4. PubMed ID: 7085244
[No Abstract] [Full Text] [Related]
24. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
25. Adrenoleukodystrophy without adrenal insufficiency and its magnetic resonance imaging.
Nishio H; Kodama S; Tsubota T; Takumi T; Takahashi T; Yokoyama S; Matsuo T
J Neurol; 1985; 232(5):265-70. PubMed ID: 4056832
[TBL] [Abstract][Full Text] [Related]
26. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
27. Characterization of X-linked adrenoleukodystrophy in different biological specimens from ten Portuguese families.
Jorge P; Quelhas D; Nogueira A
J Inherit Metab Dis; 1993; 16(1):55-62. PubMed ID: 8387613
[TBL] [Abstract][Full Text] [Related]
28. Carrier detection for adrenoleukodystrophy by high-performance liquid chromatography.
Sakai T; Antoku Y; Tsukamoto K; Imanishi K; Iwashita H; Gotoh I
Exp Neurol; 1988 Jun; 100(3):556-62. PubMed ID: 3366206
[TBL] [Abstract][Full Text] [Related]
29. Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.
Cotrufo R; Melone MA; Monsurro MR; Di Iorio G; Carella C; Moser HW
Am J Med Genet; 1987 Apr; 26(4):833-8. PubMed ID: 3591825
[TBL] [Abstract][Full Text] [Related]
30. Adrenoleukodystrophy: fatty acid analysis of total glycerophospholipids in erythrocyte membranes.
Antoku Y; Sakai T; Goto I; Katafuchi Y; Sato H; Iwashita H; Kuroiwa Y
Acta Neurol Scand; 1985 Aug; 72(2):193-7. PubMed ID: 4050328
[TBL] [Abstract][Full Text] [Related]
31. A simple method to diagnose adrenoleukodystrophy using a dried blood spot on filter paper.
Nishio H; Kodama S; Yokoyama S; Matsuo T; Mio T; Sumino K
Clin Chim Acta; 1986 Aug; 159(1):77-82. PubMed ID: 3757269
[TBL] [Abstract][Full Text] [Related]
32. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
O'Neill BP; Moser HW; Saxena KM; Marmion LC
Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
[TBL] [Abstract][Full Text] [Related]
33. A comparison of erythrocytes, lymphocytes and blood plasma as samples in fatty acid analysis for the diagnosis of adrenoleukodystrophy.
Antoku Y; Ohtsuka Y; Nagara H; Sakai T; Tsukamoto K; Iwashita H; Goto I
J Neurol Sci; 1989 Dec; 94(1-3):193-200. PubMed ID: 2614467
[TBL] [Abstract][Full Text] [Related]
34. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
Poulos A; Sharp P; Johnson D
Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
[TBL] [Abstract][Full Text] [Related]
35. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
Stradomska TJ; Tylki-Szymańska A
Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
[TBL] [Abstract][Full Text] [Related]
36. Adrenoleukodystrophy and variants. Clinical, neurophysiological and biochemical studies in patients and family members.
Goto I; Kobayashi T; Antoku Y; Tobimatsu S; Kuroiwa Y
J Neurol Sci; 1986 Jan; 72(1):103-12. PubMed ID: 3081689
[TBL] [Abstract][Full Text] [Related]
37. The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy.
Van Duyn MA; Moser AE; Brown FR; Sacktor N; Liu A; Moser HW
Am J Clin Nutr; 1984 Aug; 40(2):277-84. PubMed ID: 6465061
[TBL] [Abstract][Full Text] [Related]
38. Separation and determination of saturated very-long-chain free fatty acids in plasma of patients with adrenoleukodystrophy using solid-phase extraction and high-performance liquid chromatographic analysis.
Zamir I; Grushka E; Chemke J
J Chromatogr; 1991 Jul; 567(2):319-30. PubMed ID: 1939465
[TBL] [Abstract][Full Text] [Related]
39. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
Moser AB; Borel J; Odone A; Naidu S; Cornblath D; Sanders DB; Moser HW
Ann Neurol; 1987 Mar; 21(3):240-9. PubMed ID: 2440378
[TBL] [Abstract][Full Text] [Related]
40. Disturbed very long chain (C24-C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome.
Govaerts L; Bakkeren J; Monnens L; Maas J; Trijbels F; Kleijer W
J Inherit Metab Dis; 1985; 8(1):5-8. PubMed ID: 3921760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
